Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Witkin

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
CNS & Neurological Disorders Drug Targets|April 14, 2007
AMPA receptors in the therapeutic management of depressionD Bleakman, A Alt, J M Witkin
European Journal of Pharmacology|May 24, 1995
Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptorsJ B Acri, G Wong, J M Witkin
Psychopharmacology|January 1, 1989
Tolerance to behavioral effects of physostigmine under interval schedules of positive or negative reinforcementG Galbicka, T F Elsmore, J M Witkin
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
gamma-Aminobutyric acidA agonists differentially augment gnawing induced by indirect-acting dopamine agonists in C57BL/6J miceE Tirelli, B Geter-Douglass, J M Witkin
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaineP Terry, J M Witkin, J L Katz
Trends in Pharmacological Sciences|April 22, 1999
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disordersM Gasior, R B Carter, J M Witkin
Peptides|July 1, 1984
Potentiation of the behavioral effects of pentobarbital, chlordiazepoxide and ethanol by thyrotropin-releasing hormoneJ M Witkin, J Sickle, J E Barrett
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Chlormethiazole: effectiveness against toxic effects of cocaine in miceM Gasior, J T Ungard, J M Witkin
European Journal of Pharmacology|January 29, 2000
Lethal seizures predicted after aminophylline therapy in cocaine abusersM Gasior, J T Ungard, J M Witkin
Neuropharmacology|August 28, 2001
Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low dosesA Zapata, J M Witkin, T S Shippenberg
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
CNS & Neurological Disorders Drug Targets|April 14, 2007
AMPA receptors in the therapeutic management of depressionD Bleakman, A Alt, J M Witkin
European Journal of Pharmacology|May 24, 1995
Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptorsJ B Acri, G Wong, J M Witkin
Psychopharmacology|January 1, 1989
Tolerance to behavioral effects of physostigmine under interval schedules of positive or negative reinforcementG Galbicka, T F Elsmore, J M Witkin
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
gamma-Aminobutyric acidA agonists differentially augment gnawing induced by indirect-acting dopamine agonists in C57BL/6J miceE Tirelli, B Geter-Douglass, J M Witkin
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaineP Terry, J M Witkin, J L Katz
Trends in Pharmacological Sciences|April 22, 1999
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disordersM Gasior, R B Carter, J M Witkin
Peptides|July 1, 1984
Potentiation of the behavioral effects of pentobarbital, chlordiazepoxide and ethanol by thyrotropin-releasing hormoneJ M Witkin, J Sickle, J E Barrett
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Chlormethiazole: effectiveness against toxic effects of cocaine in miceM Gasior, J T Ungard, J M Witkin
European Journal of Pharmacology|January 29, 2000
Lethal seizures predicted after aminophylline therapy in cocaine abusersM Gasior, J T Ungard, J M Witkin
Neuropharmacology|August 28, 2001
Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low dosesA Zapata, J M Witkin, T S Shippenberg
Pageof 14